España
India
Italia
대한민국
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
PepGen
PEPG
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$1.29
-0.15
-10.42%
At close: -
$1.37
0.08
6.20%
After Hours: 7:59 PM EDT
Get Report
Comment
PepGen (PEPG) Forecast
News
Earnings
PepGen (PEPG) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for PepGen (NASDAQ:PEPG) Stock
PepGen Stock (NASDAQ: PEPG)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Thursday, January 30, 2025
PepGen shares are trading lower after HC Wain...
Benzinga Newsdesk
HC Wainwright & Co. Maintains Buy on PepGen, ...
Benzinga Newsdesk
Wednesday, January 29, 2025
PepGen Announced Updates On CONNECT Trial For...
Benzinga Newsdesk
Tuesday, December 17, 2024
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights
Monday, December 16, 2024
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights
PepGen shares are trading lower after the com...
Benzinga Newsdesk
PepGen Announces Clinical Hold In The U.S. On...
Benzinga Newsdesk
Tuesday, December 03, 2024
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights
Monday, November 18, 2024
Roku To Rally Around 31%? Here Are 10 Top Analyst Forecasts For Monday
Avi Kapoor
B of A Securities Maintains Neutral on PepGen...
Benzinga Newsdesk
Friday, November 08, 2024
Wedbush Maintains Outperform on PepGen, Lower...
Benzinga Newsdesk
HC Wainwright & Co. Reiterates Buy on PepGen,...
Benzinga Newsdesk
Thursday, November 07, 2024
PepGen shares are trading lower. The company ...
Benzinga Newsdesk
PepGen Q3 EPS $(0.66) Beats $(0.87) Estimate
Benzinga Newsdesk
Tuesday, October 01, 2024
Capricor Therapeutics Is Up Over 100%, Could Rise Even Higher
MarketBeat
Thursday, August 08, 2024
PepGen Q2 EPS $(0.87) Misses $(0.72) Estimate
Benzinga Newsdesk
Friday, August 02, 2024
Down -39.63% in 4 Weeks, Here's Why You Should You Buy the Dip in PepGen
Zacks
Thursday, August 01, 2024
HC Wainwright & Co. Reiterates Buy on PepGen,...
Benzinga Newsdesk
Wednesday, July 31, 2024
Nasdaq Surges Over 3%; Powell Industries Shares Spike Higher
Avi Kapoor
Dow Jumps Over 200 Points; Kraft Heinz Shares Gain After Q2 Earnings
Avi Kapoor
Wedbush Reiterates Outperform on PepGen, Main...
Benzinga Newsdesk
PepGen shares are trading lower. The company ...
Benzinga Newsdesk
Tuesday, July 30, 2024
PepGen shares are trading lower. The company ...
Benzinga Newsdesk
PepGen Shares Data From Low-Dose Cohort Of PG...
Benzinga Newsdesk
Friday, June 28, 2024
PepGen Files $250M Mixed Securities Shelf
Benzinga Newsdesk
Wednesday, May 15, 2024
HC Wainwright & Co. Reiterates Buy on PepGen,...
Benzinga Newsdesk
Wedbush Reiterates Outperform on PepGen, Main...
Benzinga Newsdesk
Tuesday, May 14, 2024
CORRECTION: PepGen Q1 2024 GAAP EPS $(0.63) B...
Benzinga Newsdesk
Friday, April 12, 2024
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga Insights
Wednesday, April 10, 2024
Insiders Buying GameStop And 2 Other Stocks
Avi Kapoor
Wednesday, March 13, 2024
PepGen Receives U.S. FDA Orphan Drug And Rare...
Benzinga Newsdesk
Thursday, March 07, 2024
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga Insights
PepGen shares are trading lower after the com...
Benzinga Newsdesk
PepGen Reported March 6 Q4 2023 GAAP EPS $(0....
Benzinga Newsdesk
Wedbush Maintains Outperform on PepGen, Lower...
Benzinga Newsdesk
Monday, March 04, 2024
PepGen Announces Clearance of CTA by UK Medic...
Benzinga Newsdesk
Tuesday, February 20, 2024
PepGen Receives FDA Fast Track Designation Fo...
Benzinga Newsdesk
Wednesday, February 14, 2024
Over $37M Bet On This Industrial Stock? Check Out These 4 Stocks Insiders Are Buying
Avi Kapoor
Wednesday, February 07, 2024
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga Insights
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga Insights
PepGen Reports Pricing Of Offering Of 7.53M S...
Benzinga Newsdesk
Friday, February 02, 2024
Top 4 Health Care Stocks That May Crash This Quarter
Avi Kapoor
Tuesday, January 30, 2024
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga Insights
Wedbush Reiterates Outperform on PepGen, Main...
Benzinga Newsdesk
Monday, January 08, 2024
PepGen Announced First Patient Dosed in CONNECT1-EDO51 Phase 2 Clinical Trial of PGN-EDO51 for Duchenne Muscular Dystrophy Patients Amenable to Exon 51 Skipping
Charles Gross
Monday, December 18, 2023
PepGen Announces First Patient Dosed In Phase...
Benzinga Newsdesk
Wednesday, November 15, 2023
Board Member at PepGen Acquires Company Stock Options Worth 22,686 Shares
Benzinga Insights
Wednesday, November 08, 2023
PepGen: Q3 Earnings Insights
Benzinga Insights
PepGen Q3 EPS $(0.98) Misses $(0.88) Estimate...
Benzinga Newsdesk
Thursday, October 12, 2023
The FDA Has Lifted The Full Clinical Hold And...
Benzinga Newsdesk
Show More
